Sign In
Buy NVAX
$10.19
-0.0100 (-0.0980%)
At Close: Jun 04, 2026
Assertio (ASRT) to Report Q1 Earnings: What's in the Cards?
05:20pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
On Assertio Holdings' (ASRT) Q1 earnings call, investors will focus on the sales performance of its marketed products.
Novavax (NVAX) Starts COVID-19 Booster Study in Adolescents
05:24pm, Monday, 25'th Apr 2022 Zacks Investment Research
Novavax's (NVAX) begins administering a third/booster dose of its COVID-19 vaccine in adolescents aged between 12 years and 17 years in a pivotal late-stage study.
Novavax (NVAX) Starts COVID-19 Booster Study in Adolescents
03:02pm, Monday, 25'th Apr 2022
Novavax's (NVAX) begins administering a third/booster dose of its COVID-19 vaccine in adolescents aged between 12 years and 17 years in a pivotal late-stage study.
Why Novavax Shares Are Rising
01:51pm, Monday, 25'th Apr 2022
Shares of vaccine companies, including Novavax, Inc. (NASDAQ: NVAX), are trading higher amid COVID-19 concerns due to rising cases in China. Rising COVID-19 cases in China's capital Beijing and Shangh
Does Novavax's Latest Approval Change Anything for Shareholders?
11:05am, Monday, 25'th Apr 2022 The Motley Fool
The approval of Novavax's COVID vaccine in Japan would be more notable had the company's 2021 vaccine rollout gone according to plan.
Does Novavax's Latest Approval Change Anything for Shareholders?
07:05am, Monday, 25'th Apr 2022
The approval of Novavax's COVID vaccine in Japan would be more notable had the company's 2021 vaccine rollout gone according to plan.
The FDA Will Soon Give These 3 Healthcare Companies the Green Light
08:00pm, Friday, 22'nd Apr 2022 The Motley Fool
These Fool.com contributors see happy news in the future for Novavax, Axsome Therapeutics, and Novocure.
The FDA Will Soon Give These 3 Healthcare Companies the Green Light
04:00pm, Friday, 22'nd Apr 2022
These Fool.com contributors see happy news in the future for Novavax, Axsome Therapeutics, and Novocure.
Time for Reopening-Friendly Travel & Leisure ETFs?
12:00pm, Friday, 22'nd Apr 2022 Zacks Investment Research
As the pandemic is slowly turning into an endemic, leisure and travel stocks have flied higher.
Time for Reopening-Friendly Travel & Leisure ETFs?
09:02am, Friday, 22'nd Apr 2022
As the pandemic is slowly turning into an endemic, leisure and travel stocks have flied higher.
Novavax Stock Could Give Back More of Its Pandemic-Era Gains
07:34am, Friday, 22'nd Apr 2022
While trading at a very low multiple to the low end of earnings estimates, NVAX stock may still be trading at a premium. The post Novavax Stock Could Give Back More of Its Pandemic-Era Gains appeared
Novavax (NVAX) Posts Upbeat Data on COVID/Flu Combo Jab Study
03:58pm, Thursday, 21'st Apr 2022 Zacks Investment Research
Results from Novavax's (NVAX) phase I/II study, which is evaluating a combination of its COVID-19 vaccine and the seasonal influenza vaccine candidate, demonstrate the combo vaccine's feasibility.
Is Novavax Stock in Trouble?
01:40pm, Thursday, 21'st Apr 2022 The Motley Fool
It hasn't been all smooth sailing for this biotech company.
Novavax: Management's Revenue Guidance - If It Can Be Trusted - Makes The Bull Case
01:36pm, Thursday, 21'st Apr 2022
Since my last bullish note on Novavax, the company's stock is down >60%, to $52, and a market cap valuation of $3.95bn. This seems absurdly low when we consider management is guiding for $4-$5bn reven
Novavax (NVAX) Posts Upbeat Data on COVID/Flu Combo Jab Study
01:33pm, Thursday, 21'st Apr 2022
Results from Novavax's (NVAX) phase I/II study, which is evaluating a combination of its COVID-19 vaccine and the seasonal influenza vaccine candidate, demonstrate the combo vaccine's feasibility.
